Abstract
Eight patients with epidermoid carcinoma of the penis received methotrexate, five with high-dose methotrexate, 250--1500 mg/m2 with citrovorum rescue Q 2--4 weeks, and three with low-dose methotrexate, 0.5--3.0 mg/kg weekly. Three (38%) patients achieved a complete or partial remission which persisted for 11, 3 and 2 months, respectively. Methotrexate appears to be an active agent in the treatment of advanced penile cancer.
References
Jan 1, 1977·British Journal of Urology·P S OrrR Scott
Nov 1, 1979·Cancer·R B Sklaroff, A Yagoda
Dec 1, 1972·Annals of Internal Medicine·A YagodaI H Krakoff
Jan 1, 1961·Cancer·V K VAITKEVICIUSR W TALLEY
Oct 1, 1963·Cancer·O G DODGE, C A LINSELL
Citations
Jan 1, 1989·International Urology and Nephrology·V Srinivas, S A Khan
Feb 13, 2010·Current Opinion in Oncology·José Roberto RossariThierry Gil
Aug 3, 2010·The Urologic Clinics of North America·Edouard J Trabulsi, Jean Hoffman-Censits
Mar 27, 2007·The Journal of Urology·Carlos BermejoCurtis A Pettaway
Feb 24, 2007·European Urology·Joost A P LeijteSimon Horenblas
Nov 28, 2006·BJU International·Oliver W HakenbergManfred P Wirth
Dec 1, 1984·Controlled Clinical Trials·C L MeinertK Higgins
Apr 1, 1989·Journal of Surgical Oncology·W G JonesW Van den Bogaert
Oct 23, 1998·The Journal of Urology·D A CorralJ Ellerhorst
Aug 1, 1981·Urology·R M Krieg, K H Luk
May 20, 1999·The Journal of Urology·G P HaasE D Crawford
Nov 1, 1993·Urology·J KattanC Haie-Meder
Jun 2, 2012·Therapeutic Advances in Urology·Oliver W Hakenberg, Chris Protzel
Oct 15, 1984·Cancer·R P Abratt
Jul 11, 2003·The Journal of Urology·Daniel J Culkin, Tomasz M Beer
Sep 1, 1984·The Journal of Urology·T AhmedA Yagoda
Mar 1, 1992·The Journal of Urology·F V ShammasS D Fossa
Jun 1, 1985·The Journal of Urology·F E MohsM E Kuglitsch
Apr 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TheodoreUNKNOWN EORTC Genito-Urinary Tract Cancer Group